(Q48318139)

10 February 2018

review article

1 reference

title

Unique pharmacological profile of aripiprazole as the phasic component buster (English)

1 reference

10 February 2018

1 reference

Takashi Hamamura

1

1 reference

10 February 2018

Toshiki Harada

series ordinal

2

1 reference

10 February 2018

publication date

5 January 2007

1 reference

10 February 2018

number of pages

3

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 February 2018

volume

191

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

741-743

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-006-0654-2

exact match

0 references

cites work

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0654-2

Phasic dopamine signaling during behavior, reward, and disease states

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0654-2

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-006-0654-2

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

21 January 2018

1 reference

12 December 2020

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

12 December 2020

Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action

1 reference

12 December 2020

The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons

1 reference

12 December 2020

Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission

1 reference

12 December 2020

Transient changes in mesolimbic dopamine and their association with 'reward'.

1 reference

12 December 2020

Getting formal with dopamine and reward

1 reference

12 December 2020

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

12 December 2020

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

12 December 2020

10.1007/S00213-006-0654-2

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018